At Home Blood Collection Devices Market

At Home Blood Collection Devices Market

The global at home blood collection devices market, valued at USD 1,005 million in 2025, is projected to reach USD 1,114 million in 2026 and USD 1,867 million by 2030, with a 13.8% CAGR during the forecast period 2026 to 2030.

To learn more about this report, request a free sample copy

Post the onset of COVID-19 pandemic, there has been a decline in number of patients visiting laboratories for sample collection and testing. Owing to the risk of infection associated with such places, several patients postponed their routine tests and medical checkups, in order to avoid the spread of the disease. In fact, an average decline of approximately 40% in phlebotomy appointments was reported by various laboratories across the globe. The aforementioned concerns have encouraged stakeholders to develop novel devices and technologies that can enable patients to self-collect their blood samples at-home, to monitor their health remotely.

Over 80% of the self-blood collecting devices that we came across during our research have already received marketing approval. In 2021, TAP® II and Tasso-M20 self-blood collecting devices received the CE mark from the European Commission. Further, recently, Symbiotica received emergency use authorization by the USFDA for its proprietary at-home COVID-19 serology test kit, which has been demonstrated to be capable of detecting the presence of SARS-CoV-2 using dried blood spot samples.

The at home blood collection and micro sampling devices market is fragmented, featuring a mix of start-ups / small companies and mid-sized firms. Interestingly, over 40% of the start-ups engaged in at home blood collection devices market have been established since 2014. Further, large firms are actively acquiring small industry players in order to either consolidate their existing capabilities or enter this niche domain. Consequently, there has been a significant increase in the partnership activity related to at home blood collection devices, over the past few years. In addition, both public and private investors have invested a sum of more than USD 640 million in at home blood collection devices market, since 2014. Given the rising adoption and preference for self-blood collection and blood collection at home approaches, coupled to the ongoing efforts of device developers and manufacturers to further expand their respective offerings, we believe that the at home blood collection and micro sampling devices market is likely to witness significant market growth during the forecast period.

Key Companies in At Home Blood Collection Devices Market

Examples of key companies engaged in at home blood collection devices market (which have also been profiled in this market report; the complete list of companies is available in the full report) include EUROIMMUN, Everlywell, Labcorp, Labonovum, Lameditech, Quest Diagnostics, Spot On Sciences, Tasso, Weavr Health and YourBio Health. This market report includes an easily searchable excel database of all the companies providing at home blood collection devices, worldwide.

Recent Developments in At Home Blood Collection Devices Market:

Several recent developments have taken place in the field of at home blood collection devices. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.

• In April 2026, Speedy Sticks launched a national platform for at-home blood draw and mobile phlebotomy services across major US markets.
• In March 2026, Neurogen Biomarking entered into a collaboration with Tasso where Neurogen adopts Tasso's virtually painless, needl-free blood collection devices to enhance at-home sampling capabilities for biomarker programs in decentralized clinical research.
• In February 2025, Tasso collaborated with ARUP Laboratories with an aim to develop and operationalize high-quality at-home blood testing services for clinical research, validating assays.

Scope of the Report

The “At Home Blood Collection Devices Market by Type of Blood Sample State (Dried and Liquid), Method of Sample Collection (Fingerstick and Push-Button Method), Device Usage (Single-use and Reusable), Area of Application (Diagnostics, Research, Therapeutics and Others), and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, and MENA) - Industry Trends and Global Forecasts, till 2030” market report features an extensive study of the current market landscape, market size, market share, market forecast, market outlook and future opportunities for the market. The market research report features a detailed analysis of the key drivers and trends related to this evolving domain. Amongst other elements, the market research report features:

• A detailed overview of the current market landscape of at-home self-blood collection and micro sampling devices, along with information on several relevant parameters, such as device class (class I and class II), current status of development (marketed, emergency use authorization, available for investigational use only and under development), regulatory approvals / certifications received (CE Mark, USFDA, TGA, KFDA and Health Canada), type of technology, device usage (single-use and reusable), type of sample (whole capillary blood, plasma and serum), blood sample state (dried and liquid), volume of sample collected, puncture site (fingertip, upper arm, heel and toe), method of sample collection (fingerstick and push-button method), storage temperature and application area. In addition, it presents details of the companies engaged in the development of at home blood collection and micro sampling devices, along with information on their respective year of establishment, company size, location of headquarters and most active players (in terms of number of devices).
• Elaborate profiles of key players engaged in at home blood collection devices market. Each company profile features a brief overview of the company, along with information on year of establishment, location of headquarters, number of employees, key executives, product portfolio, recent developments and an informed future outlook.
• An in-depth product competitiveness analysis of at home blood collection and micro sampling devices based on several relevant parameters, such as supplier power (in terms of expertise of the companies) and key product-related specifications (device class, current status of development, device usage, type of sample, application areas and regulatory approvals / certifications).
• A detailed analysis of various patents that have been filed / granted within at home blood collection devices market domain, since 2015. The analysis assesses several relevant parameters associated with the patents, including type of patent (granted patents and patent applications), publication year, regional applicability, CPC symbols, emerging focus areas, most active players (in terms of the number of patents filed / granted), and patent valuation.
• An analysis of the recent partnerships inked between various players engaged in market, during the period since 2014, based on several relevant parameters, such as year of partnership, type of partnership model adopted, focus area, therapeutic area and regional distribution. 
• A detailed analysis of various investments made by players engaged in at home blood collection devices market, based on several relevant parameters, such as year of investment, number of funding instances, amount invested and type of funding (grant, debt, seed, venture capital, initial public offering (IPO) and other equity), along with information on the most active players (in terms of number of funding instances and amount raised), most active investors (in terms of number of funding instances), geographical distribution, purpose of investment and application area.
• An insightful analysis highlighting the cost saving potential associated with at-home self-blood collection and micro sampling devices, taking into consideration several relevant parameters.

Please click on the preview above to view the video

The key objective of the market report is to provide a detailed market analysis in order to estimate the existing market size, market value, statistics and future opportunity for at home blood collection devices market during the forecast period. We have also provided an informed estimate on the likely evolution of the market in the short to mid-term and long term, over the forecast period till 2035. Additionally, the market report features the likely distribution of the current and forecasted opportunity across [A] blood sample state (dried and liquid), [B] method of sample collection (fingerstick and push-button method), [C] device usage (single-use and reusable), [D] area of application (diagnostics, research, therapeutics and others), and [E] key geographical regions (North America, Europe, Asia-Pacific, Latin America, and MENA). In order to account for future uncertainties and add robustness to our forecast model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market research report are in USD, unless otherwise specified.

Frequently Asked Questions

Question 1: What are at home blood collection devices?

Answer: At home blood collection devices are easy to use sampling devices, which can be used by the patient themselves to collect blood samples at their home.

Question 2: How big is the at home blood collection devices market?

Answer: The at home blood collection devices market size is estimated to be worth $1,114 million in 2026.

Question 3: What is the projected market growth of the at home blood collection devices market?

Answer: The at home blood collection devices market is expected to grow at compounded annual growth rate (CAGR) of over 13.8% during the forecast period.

Question 4: Who are the leading companies in the at home blood collection devices market?

Answer: Examples of key companies engaged in at home blood collection devices market (which have also been profiled in this market report; the complete list of companies is available in the full report) include EUROIMMUN, Everlywell, Labcorp, Labonovum, Lameditech, Quest Diagnostics, Spot On Sciences, Tasso, Weavr Health and YourBio Health.

Question 5: What is the cost saving potential of at home blood collection devices?

Answer: At home blood collection devices can save up to 60% in the overall cost of diagnostic procedures.

Question 6: How many at home blood collection devices are currently available?

Answer: Over 45 at home blood collection devices are currently available in the market.

Question 7: How much money has been invested by stakeholders in the at home blood collection devices market?

Answer: More than USD 650 million has been invested by stakeholders in the at home blood collection devices market, highlighting the rising interest of players in the industry.